Category : Search result: Indian pharma exports


US Tariffs Cut India's Gem Exports by 44%

India's gem and jewellery exports to the US plunged 44% in April-Dec 2025, hitting $3.86 billion. Industry warns of job cuts and long-term market risks due to tariffs.

India's Exports to China Jump 33% in 8 Months

India's exports to China grew by 33% from April to November 2025, driven by oil meals, telecom gear, and spices. Discover the key drivers behind this major trade shift.

Leather Sector Seeks Help Over High US Tariffs

Indian leather exporters warn Parliament panel that 50% US tariffs are crippling exports and jobs. They urge government intervention and market diversification. Read more.

EU Carbon Tax to Hit Indian Metal Exports from 2026

Indian steel and aluminium exports to the EU will face a carbon-linked cost from 2026 under CBAM. GTRI report warns of 15-22% price cuts for competitiveness, disproportionately impacting MSMEs. Learn the key compliance challenges.

UV Exports Overtake Passenger Cars in Historic Shift

India's auto exports see a historic reversal as Utility Vehicle shipments surpass passenger cars for the first time in November. Discover the data, key players, and what this means for 'Make in India'. Read the full analysis.

Aurobindo Pharma increases stake in China JV to 50%

Aurobindo Pharma's Dutch arm buys 20% more in China's Luoxin Aurovitas for $5M, aiming for 100% ownership by 2029 to scale up inhalation product manufacturing. Read the full strategic move.

India Pharma Targets $500B, Innovation Hub by 2047

India's pharmaceutical industry gears up for a critical 5-year phase from 2026, aiming to become a $500 billion innovation hub by 2047. Learn how it plans to tackle challenges and seize opportunities.

Page 1 of 4